Human umbilical cord mesenchymal stem cells improve morphometric and histopathologic changes of cyclophosphamide-injured ovarian follicles in mouse model of premature ovarian failure

被引:16
|
作者
Jalalie, Ladan [1 ,2 ]
Rezaee, Mohammad Ali [3 ,4 ]
Rezaie, Mohammad Jafar [1 ,5 ]
Jalili, Ali [6 ]
Raoofi, Amir [7 ]
Rustamzade, Auob [8 ]
机构
[1] Kurdistan Univ Med Sci, Cellular & Mol Res Ctr, Res Inst Hlth Dev, POB 66177-13446, Sanandaj, Iran
[2] Orumiah Univ Med Sci, Motahary Hosp, Orumiah, Iran
[3] Kurdistan Univ Med Sci, Zoonoses Res Ctr, Res Inst Hlth Dev, Sanandaj, Iran
[4] Kurdistan Univ Med Sci, Fac Paramed, Dept Med Lab Sci, Sanandaj, Iran
[5] Kurdistan Univ Med Sci, Fac Med, Dept Anat Sci, Sanandaj, Iran
[6] Kurdistan Univ Med Sci, Fac Med, Dept Immunol & Hematol, Sanandaj, Iran
[7] Sabzevar Univ Med Sci, Leishmaniasis Res Ctr, Dept Anat, Sabzevar, Iran
[8] Iran Univ Med Sci, Fac Med, Dept Anat Sci, Student Res Comm, Tehran, Iran
关键词
Premature ovarian failure; Mesenchymal stem cells; Cyclophosphamide; Follicular quantitative parameters; Apoptosis; CHEMOTHERAPY; DAMAGE;
D O I
10.1016/j.acthis.2020.151658
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Mesenchymal stem cells have restorative effects on premature ovarian failure (POF). The aim of this study was to investigate the effects of human umbilical cord vein MSCs (hUCV-MSCs) on follicular quantitative parameters and histological changes of ovaries in the cyclophosphamide (CTX)-induced POF in mice. Materials and methods: C57BL/6 mice were divided into three groups (10 mice in each group). In the control group, phosphate-buffered saline (PBS) was injected via tail vein following 15 days injection of PBS intraperitoneally (IP). In the CTX group, CTX was administered IP for 15 days and then PBS was injected via tail vein. In the CTX + hUCV-MSCs group, following CTX administration, single dose of the 1 x 10(6) of hUCV-MSCs were injected into tail vein. H&E, trichrome and PAS staining as well as TUNEL assay were performed on the ovaries tissue sections. The number of follicles, follicular quantitative parameters and apoptotic index were obtained. The serum levels of estradiol and FSH were measured in the mice. Results: In the CTX + hUCV-MSCs group, degenerative changes were decreased and follicular quantitative parameters increased in the ovarian follicles compared to the CTX group. In this group number of follicles was increased, apoptotic index was decreased, estradiol and FSH levels were decreased and increased, respectively, all of them improved compared to the CTX group. The mean percentage areas of collagen fibers content were decreased compared to the CTX group. Conclusion: Results showed that, hUCV-MSCs administration increases follicular quantitative parameters and improve degenerative changes in the Yfollicles following CTX injury.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] Human Umbilical Cord Mesenchymal Stem Cells Therapy in Cyclophosphamide-Induced Premature Ovarian Failure Rat Model
    Song, Dan
    Zhong, Yun
    Qian, Chunfeng
    Zou, Qinyan
    Ou, Jian
    Shi, Yichao
    Gao, Liang
    Wang, Gaigai
    Liu, Zhenxing
    Li, Haibo
    Ding, Hailei
    Wu, Huihua
    Wang, Fuxin
    Wang, Jing
    Li, Hong
    BIOMED RESEARCH INTERNATIONAL, 2016, 2016
  • [2] Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure
    Shareghi-oskoue, Oldouz
    Aghebati-Maleki, Leili
    Yousefi, Mehdi
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [3] Transplantation of human umbilical cord mesenchymal stem cells to treat premature ovarian failure
    Oldouz Shareghi-oskoue
    Leili Aghebati-Maleki
    Mehdi Yousefi
    Stem Cell Research & Therapy, 12
  • [4] Human umbilical cord mesenchymal stem cells (hUCMSCs) promotes the recovery of ovarian function in a rat model of premature ovarian failure (POF)
    Zhang, Xunyi
    Zhang, Lina
    Li, Ying
    Yin, Zhe
    Feng, Yun
    Ji, Yazhong
    GYNECOLOGICAL ENDOCRINOLOGY, 2021, 37 (04) : 353 - 357
  • [5] The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure
    Amna Umer
    Nasar Khan
    David Lawrence Greene
    Umm E. Habiba
    Sabiha Shamim
    Asma Umer Khayam
    Stem Cell Reviews and Reports, 2023, 19 : 651 - 666
  • [6] The Therapeutic Potential of Umbilical Cord Mesenchymal Stem Cells in Mice Premature Ovarian Failure
    Wang, Shufang
    Yu, Ling
    Sun, Min
    Mu, Sha
    Wang, Changyong
    Wang, Deqing
    Yao, Yuanqing
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [7] The Therapeutic Potential of Human Umbilical Cord Derived Mesenchymal Stem Cells for the Treatment of Premature Ovarian Failure
    Umer, Amna
    Khan, Nasar
    Greene, David Lawrence
    Habiba, Umm E.
    Shamim, Sabiha
    Khayam, Asma Umer
    STEM CELL REVIEWS AND REPORTS, 2023, 19 (03) : 651 - 666
  • [8] Matrigel/Umbilical Cord-Derived Mesenchymal Stem Cells Promote Granulosa Cell Proliferation and Ovarian Vascularization in a Mouse Model of Premature Ovarian Failure
    Zhou, Yao
    Zhou, Jinhua
    Xu, Xi
    Du, Fangzhou
    Nie, Mengting
    Hu, Lvzhong
    Ma, Yuhao
    Liu, Mengmeng
    Yu, Shuang
    Zhang, Jingzhong
    Chen, Youguo
    STEM CELLS AND DEVELOPMENT, 2021, 30 (15) : 782 - 796
  • [9] Ability of human umbilical cord mesenchymal stem cells to repair chemotherapy-induced premature ovarian failure
    Shen, Jian
    Cao, Dai
    Sun, Jing-Li
    WORLD JOURNAL OF STEM CELLS, 2020, 12 (04): : 277 - 287
  • [10] Human umbilical cord mesenchymal stem cells restore the ovarian metabolome and rescue premature ovarian insufficiency in mice
    Zhao, Yan
    Ma, Jiao
    Yi, Peiye
    Wu, Jun
    Zhao, Feiyan
    Tu, Wan
    Liu, Wenjing
    Li, Tianda
    Deng, Yan
    Hao, Jie
    Wang, Hongmei
    Yan, Long
    STEM CELL RESEARCH & THERAPY, 2020, 11 (01)